Commencement of flash glucose monitoring is associated with a decreased rate of depressive disorders among persons with diabetes (FLARE-NL7).
Julia J BakkerAnnel LameijerJose-Luis Flores GuerreroHenk J G BiloPeter Ruben van DijkPublished in: BMJ open diabetes research & care (2022)
This analysis suggests that use of FSL-FGM is associated with a decreased rate of depressive disorders among persons with diabetes. Future studies are needed to corroborate these findings.